The microenvironment of tumor tissues varies widely, and the presence of other cell types can affect the ability of the immune system to infiltrate and attack tumor cells. As promising new therapies develop, there is an increasing need to identify cancer immunotherapy biomarkers to guide their proper application. NGS can provide a careful analysis of the cancer genome and can effectively assess the tumor environment as a real-time, highly sensitive immune marker expression monitor that responds to tumor growth or treatment. NGS analysis can be used to characterize immune cell banks, identify various cell populations in the microenvironment, and comprehensively quantify gene expression for thousands of targets simultaneously.
Method display
Epigenetic analysis of cancer samples
Research on epigenetic changes in cancer. Because changes in methylation usually activate or silence genes, changes in the epigenome can affect gene expression and the rate of cancer progression. NGS and microarray technology can detect changes in methylation patterns and other epigenetic changes in cancer.
RNA sequencing
RNA analysis can help identify tumor microenvironments that may affect the effectiveness of checkpoint immunotherapy, such as inducible and inhibitory cytokines, and local recruitment of other cell types that can suppress T-cell responses.
Cancer research bioinformatics
Cancer researchers need easy-to-use bioinformatics applications to gain insights from complex genomic data. The BaseSpace queue analyzer enables biologists and researchers to make important discoveries without the need for specialized bioinformatics skills. Retrospective analysis of clinical trial data can help inform future cancer research and drug development programs.
Creative Proteomics leads a rich team that uses the most rigorous experimental solutions and internationally recognized experimental techniques for Tumor microenvironment and immunity Solutions to obtain your customized information. Use the most accurate experimental results to help you better carry out tumor-related scientific research.
Our advantage
Mature and reliable Tumor microenvironment and immunity Solutions platform: rich project experience, participate in major projects, and publish high-level cooperation results.
The analysis contents and methods based on high-quality data analysis, pre-research and verification are indeed mature and feasible
* For Research Use Only. Not for use in the treatment or diagnosis of disease.
Related Services:
